ChartRow logo
Data provided bySource: Twelve Data
SMMT
$10.67-9.73%
as of close, Nov 17, 2026
☾ AH $10.67 -9.73%
PeersBBIOBNTXASNDARGXGHPRAX
Share this page

Summit Therapeutics Inc. Common Stock monthly returns

Summit Therapeutics Inc. Common Stock has averaged 4.92% a month with dividends reinvested, and risen in 44% of months, through November 17, 2026. The table lists the most recent months; the chart, the last 5 years.

Average month
+4.9%
140 months
Best month
+431.3%
Dec 2022
Worst month
-81.6%
Jun 2018
Positive months
44%
of all months
Summit Therapeutics Inc. Common Stock total return by month
MonthTotal return
Nov 2026
-33.4%
Oct 2026
-5.2%
Sep 2026
+24.2%
Aug 2026
+4.6%
Jul 2026
-10.6%
Jun 2026
-16.9%
May 2026
-18.3%
Apr 2026
+13.2%
Mar 2026
+14.3%
Feb 2026
+14.6%
Jan 2026
-17.2%
Dec 2025
-2.2%
Nov 2025
-5.4%
Oct 2025
-8.5%
Sep 2025
-12.8%
Aug 2025
-10.1%
Jul 2025
+23.9%
Jun 2025
+16.8%
May 2025
-24.5%
Apr 2025
+25.0%
Mar 2025
-6.8%
Feb 2025
-3.8%
Jan 2025
+20.5%
Dec 2024
-3.3%
Nov 2024
-0.7%
Oct 2024
-15.1%
Sep 2024
+68.7%
Aug 2024
+20.2%
Jul 2024
+38.5%
Jun 2024
-10.2%
May 2024
+121.0%
Apr 2024
-5.1%
Mar 2024
-8.8%
Feb 2024
+15.8%
Jan 2024
+50.2%
Dec 2023
+28.6%
Nov 2023
+4.6%
Oct 2023
+3.7%
Sep 2023
+15.4%
Aug 2023
-22.9%
Jul 2023
-16.3%
Jun 2023
+54.0%
May 2023
+23.5%
Apr 2023
-24.6%
Mar 2023
-2.8%
Feb 2023
-49.3%
Jan 2023
-16.5%
Dec 2022
+431.3%
Nov 2022
-26.6%
Oct 2022
-8.4%
Sep 2022
-0.8%
Aug 2022
+18.8%
Jul 2022
+1.0%
Jun 2022
-24.8%
May 2022
-16.4%
Apr 2022
-35.1%
Mar 2022
-10.6%
Feb 2022
+24.5%
Jan 2022
-18.2%
Dec 2021
-47.0%
Nov 2021
-1.6%
Oct 2021
+3.0%
Sep 2021
-37.1%
Aug 2021
+8.7%
Jul 2021
-1.7%
Jun 2021
-4.6%
May 2021
+22.8%
Apr 2021
+8.5%
Mar 2021
-13.3%
Feb 2021
-2.7%
Jan 2021
+48.1%
Dec 2020
+4.4%
Nov 2020
+37.6%
Oct 2020
-4.9%
Sep 2020
-0.3%
Aug 2020
-4.7%
Jul 2020
+21.9%
Jun 2020
-26.5%
May 2020
+7.7%
Apr 2020
+58.2%
Mar 2020
+71.7%
Feb 2020
-9.8%
Jan 2020
-4.4%
Dec 2019
+6.7%
Nov 2019
-9.1%
Oct 2019
-7.8%
Sep 2019
+33.9%
Aug 2019
+1.3%
Jul 2019
+4.3%
Jun 2019
-16.8%
May 2019
-13.9%
Apr 2019
-3.6%
Mar 2019
-20.4%
Feb 2019
+72.9%
Jan 2019
+15.7%
Dec 2018
-11.5%
Nov 2018
-23.5%
Oct 2018
-23.4%
Sep 2018
-5.5%
Aug 2018
+2.2%
Jul 2018
-6.1%
Jun 2018
-81.6%
May 2018
+2.5%
Apr 2018
+1.0%
Mar 2018
+10.2%
Feb 2018
-14.7%
Jan 2018
+23.9%
Dec 2017
-5.9%
Nov 2017
+14.5%
Oct 2017
-18.1%
Sep 2017
-2.5%
Aug 2017
-7.9%
Jul 2017
+22.7%
Jun 2017
+2.4%
May 2017
+1.1%
Apr 2017
-17.1%
Mar 2017
+8.7%
Feb 2017
+16.6%
Jan 2017
+22.3%
Dec 2016
-18.4%

Monthly total return (since Dec 2021)#

Summit Therapeutics Inc. Common Stock returns by calendar month#

Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.

November 2026 so far: -33.44% — 12th of 12 Novembers since 2015 at the last close; the average November returned -1.6%.

Summit Therapeutics Inc. Common Stock returns by calendar month since 2015
Month−435%0+435%AverageUp
Jan+9.3%55%
Feb+3.6%45%
Mar+3.9%45%
Apr+4.3%50%
May+7.6%50%
Jun-9.4%33%
Jul+7.2%58%
Aug-0.3%50%
Sep+8.9%42%
Oct-4.8%25%
NovNovember 2026 so far: -33.4%-1.6%36%
Dec+35.7%45%

Methodology#

Monthly returns are total returns (dividends reinvested), computed from SMMT's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

FAQ#

What is Summit Therapeutics Inc. Common Stock's average monthly return?
Summit Therapeutics Inc. Common Stock has averaged about 4.92% per month (dividends reinvested), positive in roughly 44% of months. The best month was Dec 2022 (+431.3%) and the worst was Jun 2018 (-81.6%).

More on Summit Therapeutics Inc. Common Stock